Citation: Re. Kiernan et al., ROLE OF MATRIX IN AN EARLY POSTENTRY STEP IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LIFE-CYCLE, Journal of virology, 72(5), 1998, pp. 4116-4126
Citation: Re. Kiernan et Eo. Freed, CLEAVAGE OF THE MURINE LEUKEMIA-VIRUS TRANSMEMBRANE ENV PROTEIN BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE - TRANSDOMINANT INHIBITION BY MATRIX MUTATIONS, Journal of virology (Print), 72(12), 1998, pp. 9621-9627
Citation: A. Ono et al., CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MATRIX REVERTANTS - EFFECTS ON VIRUS ASSEMBLY, GAG PROCESSING, AND ENV INCORPORATION INTO VIRIONS, Journal of virology, 71(6), 1997, pp. 4409-4418
Authors:
DELAHUNTY MD
RHEE I
FREED EO
BONIFACINO JS
Citation: Md. Delahunty et al., MUTATIONAL ANALYSIS OF THE FUSION PEPTIDE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - IDENTIFICATION OF CRITICAL GLYCINE RESIDUES, Virology, 218(1), 1996, pp. 94-102
Authors:
WILLEY RL
SHIBATA R
FREED EO
CHO MW
MARTIN MA
Citation: Rl. Willey et al., DIFFERENTIAL GLYCOSYLATION, VIRION INCORPORATION, AND SENSITIVITY TO NEUTRALIZING ANTIBODIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PRODUCED FROM INFECTED PRIMARY T-LYMPHOCYTE AND MACROPHAGE CULTURES, Journal of virology, 70(9), 1996, pp. 6431-6436
Citation: Eo. Freed et Ma. Martin, DOMAINS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MATRIX AND GP41 CYTOPLASMIC TAIL REQUIRED FOR ENVELOPE INCORPORATION INTO VIRIONS, Journal of virology, 70(1), 1996, pp. 341-351
Citation: Eo. Freed et al., ROLE OF THE BASIC DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MATRIX IN MACROPHAGE INFECTION, Journal of virology, 69(6), 1995, pp. 3949-3954
Authors:
ENGLUND G
THEODORE TS
FREED EO
ENGELMAN A
MARTIN MA
Citation: G. Englund et al., INTEGRATION IS REQUIRED FOR PRODUCTIVE INFECTION OF MONOCYTE-DERIVED MACROPHAGES BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology, 69(5), 1995, pp. 3216-3219
Citation: Eo. Freed et Ma. Martin, VIRION INCORPORATION OF ENVELOPE GLYCOPROTEINS WITH LONG BUT NOT SHORT CYTOPLASMIC TAILS IS BLOCKED BY SPECIFIC, SINGLE AMINO-ACID SUBSTITUTIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MATRIX, Journal of virology, 69(3), 1995, pp. 1984-1989
Citation: Gl. Buchschacher et al., EFFECTS OF 2ND-SITE MUTATIONS ON DOMINANT INTERFERENCE BY A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN MUTANT, Journal of virology, 69(2), 1995, pp. 1344-1348
Citation: Mj. Huang et al., P6(GAG) IS REQUIRED FOR PARTICLE-PRODUCTION FROM FULL-LENGTH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MOLECULAR CLONES EXPRESSING PROTEASE, Journal of virology, 69(11), 1995, pp. 6810-6818
Citation: Eo. Freed et Ma. Martin, THE ROLE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS IN VIRUS-INFECTION, The Journal of biological chemistry, 270(41), 1995, pp. 23883-23886
Authors:
FREED EO
ORENSTEIN JM
BUCKLERWHITE AJ
MARTIN MA
Citation: Eo. Freed et al., SINGLE AMINO-ACID CHANGES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MATRIX PROTEIN BLOCK VIRUS PARTICLE-PRODUCTION, Journal of virology, 68(8), 1994, pp. 5311-5320
Citation: Eo. Freed et Ma. Martin, EVIDENCE FOR A FUNCTIONAL INTERACTION BETWEEN THE V1 V2 AND C4 DOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP120/, Journal of virology, 68(4), 1994, pp. 2503-2512